The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Another great Rns
Welcome to aim. Market makers innit
Why's my 8000 buy showing as a sell?
Great news!
Opens the doorway for deeper relations with Thermo Fisher and also other JV/collaborations!
GL.
Great rns people should be very interested in this share
A distinct lack of interest it seems. For now
This ain’t going to well
I was in work so was watching but never got all the detail, however I didn't hear anything that we haven't heard before. More of a confirmation the company is on the right path although did mention possibility of more deals with Thermo in time. I don't expect the share price to go up massively on the back of it.
Would love to be wrong of course.
I can't really remember much it was just her tone I picked up on. It's not going to have explosive growth but its going to be big was the nub of it.
Spill the beans then 🤔
Mmm. That was a very confident woman.
It would make sense to have an investor call alongside confirmations of the median rate for both Tutivia and Clarava. And the commercial use of the latter ahead of the call.
I missed the 9am deadline, but hopefully if no RNS tomorrow they will confirm these are still objectives for 2023.
Lets hope it leads to a SP breakout as this tight range seems hard to break.
In my mind very undervalued.
GL.
My bad, miss read the RSS, via the Investor Meet Company platform on 22 November 2023 at 17.00 (GMT).
I think you've gained a day Warren. Its 5pm 22nd.
Is the presentation not today?
One more day left for the presentation.
This share is a sleeping giant for sure :)
Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that Sara Barrington, CEO, will provide a live presentation relating to the Company's recent global licensing and commercialisation agreement for its pre-transplant test (Clarava?) with Thermo Fisher Scientific (https://verici-dx-plc.flint-platform.com/regulatory-news/44270), via the Investor Meet Company platform on 22 November 2023 at 17.00 (GMT).
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet VERICI DX PLC via:
https://www.investormeetcompany.com/verici-dx-plc/register-investor
Yeah I’m not sure they’re quite done yet
Ok, a quick review of the shareholder cap table suggests the recent and ongoing seller is/was Marlborough Fund Managers and they're now done by the looks of it. They only had 90k shares left out of 1.6m from May-22 when they started selling. The only other sellers I can see are retail/private client brokers.
In this case, it looks like the overhang should now be firmly behind us and hopefully, this puts a bit more wind in the sails of the share price!
There may therefore not be a TR1 for this sale but perhaps there may be one or two for any new fund managers joining the party...
Looks about right to me, expect TR1s next week or two, not sure why they don’t get published T+2 or 3.
I’m in for a punt looks good to me
Verici Dx signs exclusive global licensing agreement with Thermo Fisher Scientific for pre-transplant prognostic testing
Key highlights:
✅Verici Dx has granted Thermo Fisher Scientific an exclusive global license to further develop an assay for pre-transplant risk assessment for early kidney rejection.
✅The agreement includes an upfront payment of $5 million, along with ongoing royalties on tests sold.
✅Thermo Fisher Scientific will also have non-exclusive access to a portion of Verici Dx's urine biorepository.
Impact:
✅The agreement is expected to accelerate the development of Verici Dx's technology and help it reach more patients.
✅The collaboration will expand Thermo Fisher Scientific's portfolio of transplant testing solutions.
✅This is a positive development for kidney transplant patients, as it could lead to earlier diagnosis and treatment of organ rejection.